Yale presents 4 AI cardiometabolic disease studies at AHA26, 3 with simultaneous publications
BrdKhsrv · x · 2026-11-05
A Yale School of Medicine team will present 4 AI-driven cardiometabolic disease studies at AHA26 in Chicago on November 7, three with simultaneous publications:
- AI-guided adiposity phenotyping on CCTA to stratify cardiovascular risk in non-obese adults without incretin indications
- AI-enabled echocardiographic phenotyping for heart failure risk prediction in a sex-stratified multiethnic cohort
- PanAdipo: turning routine echocardiography into an AI-enabled epicardial adiposity biomarker
- A life-course analysis of cumulative cardiovascular-kidney-metabolic burden using MESA and CARDIA
Themes include hidden adiposity and AI-echo biomarkers — a concrete AI for Science application in clinical cardiology.
More from Research
- Weight space programming spawns a Rube Goldberg machine where parts have tiny brains — _ScottCondron · 2026-11-05
- Claude read all 3,096 ASHG abstracts to surface 33 human genetics highlights — anshulkundaje · 2026-11-05
- Stanford's James Zou on AI agents entering the wet lab, in Nature — james_y_zou · 2026-11-05
- Hamel Husain: Benchmarks are used like credit scores, so criticism is warranted — HamelHusain · 2026-11-05
- ArkenOS now runs on Rust, freeing room for more parallel agents — _AustinCalvert_ · 2026-11-05
- CoRL paper GUILD: actively guiding robot data collection toward useful auxiliary tasks — RobobertoMM · 2026-11-05